DW Unveils New Biotechnology Practice to be Based in Ann Arbor

<b>Dickinson Wright Unveils New Biotechnology Practice to be Based in Ann Arbor </b>

March 2005
ANN ARBOR, Mich. (March 17, 2005)—Dickinson Wright today announced that the Firm has created a biotechnology practice to be based in Ann Arbor, one of the nation's largest scientific corridors. The biotechnology practice will be led by John M. Naber, a well-known expert in the field. John will practice in the Ann Arbor and Washington D.C. offices as a Member of the Firm. Also joining the Firm's Washington D.C. office as a Legal Consultant for the biotechnology practice is Eggerton A. Campbell, Ph.D., a former Primary Examiner in the U.S. Patent and Trademark Office. The multidisciplinary biotechnology practice will provide a full range of legal services to clients, regardless of their stage of development. The practice will enable clients to address strategic business issues including the development of intellectual property in the biotechnology industry, such as patents, trademarks, copyrights and trade secrets. Additionally, the practice will seek to exploit the intellectual property through the sale, licensing or product development of the technology, which may ultimately require government approval. John represents clients in intellectual property, licensing, mergers and acquisitions, and product development matters. Presently, eighty percent of his work comes from biotechnology and pharmaceutical clients. John began his career in science as a cytogenetics technician at Children's Hospital in Cincinnati and then as the genetics program coordinator for the Delaware Department of Public Health. In 1987, he relocated to Michigan and until 2000 was a genetic consultant responsible for a genetics newborn screening program for the Michigan Department of Community Health. During this time, John attended night school at the Thomas M. Cooley Law School, graduating with distinction and as a member of the Law Review. While still consulting in genetics, John clerked for an attorney in the Lansing area, and in 1993, started his own law firm. Seven years later, he expanded his practice, joining Foster, Swift, Collins & Smith in Lansing, where he became a shareholder in January 2004. John received a B.S. from the University of Cincinnati and a M.S. in microbiology, with an emphasis in human genetics. As a former Primary Examiner in the U.S. Patent and Trademark Office, Dr. Campbell specialized in a variety of disciplines. In 1996, he was independently responsible for patent application review and was granted Full Signatory to award patents and make Final determination of patentability. During his nine years with the U.S. Patent and Trademark Office he examined over 1000 complex Biotechnology Utility Patent Applications and issued over 400 U.S. Biotechnology Utility Patents. Dr. Campbell's written technical analysis and determinations of patentability have been reviewed and affirmed by the U.S. Federal Court, Board of Appeals and Interferences on multiple occasions. He has also examined and processed written opinions on over 400 international Patent Cooperative Treaty applications. He holds a B.S. in Biochemistry from the State University of New York at Stony Brook, as well as a M.Sc. and Ph.D. in Biochemistry from Albert Einstein College of Medicine. Additionally, he completed a postdoctoral fellowship with the Institute of Allergy and Infectious Diseases at the National Institute of Health. About Dickinson Wright Dickinson Wright PLLC, founded in 1878, has more than 200 attorneys in offices located in Detroit, Bloomfield Hills, Lansing, Grand Rapids, Ann Arbor, and Washington, D.C. Dickinson Wright is a full-service law firm with more than 40 practice areas. For more information, visit www.dickinsonwright.com.
  • |